Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 135.05
-5.05 %
$ 21.4 B
Market Cap
-13.55
P/E
Price Target
Average
10.78%
Revenue Forecast
Estimate
4.53%
EBIT
Estimate
11.69%
Net Income
Estimate
30.72%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Illumina, Inc.
Wall Street analysts predict an average 1-year price target for ILMN of $150 , with forecasts ranging from a low of $58 to a high of $200 .
ILMN Lowest Price Target
Wall Street Target
58 USD
-57.05%
ILMN Average Price Target
Wall Street Target
150 USD
10.78%
ILMN Highest Price Target
Wall Street Target
200 USD
48.09%
REVENUE FORECAST
Revenue Forecast Chart ILMN
EBIT FORECAST
EBIT Forecast Chart ILMN
NET INCOME FORECAST
Net Income Chart ILMN